about
In vivo Magnetic Resonance Metabolic and Morphofunctional Fingerprints in Experimental Models of Human Ovarian CancerCholine Metabolism Alteration: A Focus on Ovarian CancerKey Players in Choline Metabolic Reprograming in Triple-Negative Breast CancerH2S-releasing nanoemulsions: a new formulation to inhibit tumor cells proliferation and improve tissue repair.Metabolic alterations in K562 cells exposed to taxol and tyrphostin AG957: 1H NMR and biochemical studies.Rhodanese-thioredoxin system and allyl sulfur compounds.Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells.Phosphatidylcholine-specific phospholipase C inhibition down- regulates CXCR4 expression and interferes with proliferation, invasion and glycolysis in glioma cells.Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.Oxidative species and S-glutathionyl conjugates in the apoptosis induction by allyl thiosulfate.The role of CSA and CSB protein in the oxidative stress response.Inhibition of Phosphatidylcholine-Specific Phospholipase C Interferes with Proliferation and Survival of Tumor Initiating Cells in Squamous Cell CarcinomaCytotoxic and genotoxic effects mediated by M2 muscarinic receptor activation in human glioblastoma cells.An altered redox balance and increased genetic instability characterize primary fibroblasts derived from xeroderma pigmentosum group A patients.Applicability of Under Vacuum Fresh Tissue Sealing and Cooling to Omics Analysis of Tumor Tissues.Detection of polyol accumulation in a new ovarian carcinoma cell line, CABA I: a(1)H NMR study.Glucose restriction induces cell death in parental but not in homeodomain-interacting protein kinase 2-depleted RKO colon cancer cells: molecular mechanisms and implications for tumor therapyPeroxynitrite signaling in human erythrocytes: synergistic role of hemoglobin oxidation and band 3 tyrosine phosphorylation.Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer.Monitoring response to cytostatic cisplatin in a HER2(+) ovary cancer model by MRI and in vitro and in vivo MR spectroscopy.MR evaluation of response to targeted treatment in cancer cells.The nitrobenzoxadiazole derivative MC3181 blocks melanoma invasion and metastasisCharacterisation of in vivo ovarian cancer models by quantitative 1H magnetic resonance spectroscopy and diffusion-weighted imaging.Glycolytic phenotype and AMP kinase modify the pathologic response of tumor xenografts to VEGF neutralization.The fine tuning of metabolism, autophagy and differentiation during in vitro myogenesis.Alterations of choline phospholipid metabolism in ovarian tumor progression.Activation of Phosphatidylcholine-Specific Phospholipase C in Breast and Ovarian Cancer: Impact on MRS-Detected Choline Metabolic Profile and Perspectives for Targeted TherapyIn K562 and HL60 cells membrane ageing during cell growth is associated with changes in cholesterol concentration.Coordinated Metabolic Changes and Modulation of Autophagy during Myogenesis.Editorial: Exploring Cancer Metabolic Reprogramming through Molecular Imaging.An altered redox balance mediates the hypersensitivity of Cockayne syndrome primary fibroblasts to oxidative stress.1H NMR-visible mobile lipid domains correlate with cytoplasmic lipid bodies in apoptotic T-lymphoblastoid cells.Two-step formation of 1H NMR visible mobile lipids during apoptosis of paclitaxel-treated K562 cells.Candida albicans cell wall comprises a branched beta-D-(1-->6)-glucan with beta-D-(1-->3)-side chains.Phosphatidylcholine-specific phospholipase C activation in epithelial ovarian cancer cells.beta-Glucan of Candida albicans cell wall causes the subversion of human monocyte differentiation into dendritic cells.Abnormal Choline Phospholipid Metabolism in Breast and Ovary Cancer:Molecular Bases for Noninvasive Imaging ApproachesIntegration of MRI and MRS approaches to monitor molecular imaging and metabolomic effects of trabectedin on a preclinical ovarian cancer modelPhosphocholine and phosphoethanolamine during chick embryo myogenesis: a (31)P-NMR studyRewiring of Lipid Metabolism and Storage in Ovarian Cancer Cells after Anti-VEGF Therapy
P50
Q26742109-34C1FCD3-6BCA-4BEF-91D2-99B501540C1AQ26742116-71B980E7-FC73-44C6-BC75-87A847C414E3Q28074613-C70101A8-5DE4-4D7D-BCA0-191D4F7842ECQ30358087-50DAD5C2-A6DE-477E-B162-2A6F5C7B3787Q31007020-8CCB0800-D8D4-4241-AEB1-56FA08FFF4E7Q31162170-44C511A4-64A5-493B-8616-9C3C6A0778F7Q33576337-40193416-D321-4BCC-8ADF-C89D780A2229Q33580152-A7EE2A62-6CE3-44C6-890C-6B70AED2246BQ33699139-182EAE77-C86B-4D46-BB70-EDD1F1E99CEAQ34060934-143DA953-6C11-443C-BECC-AE9562B66A4AQ34337569-11E1557E-63CE-4164-B267-8A8AC4AC4C35Q35786713-55980C35-AC6E-485F-98CC-7B19E05ED2CCQ35802759-C9C405D1-1717-4638-9B00-FF53B98B842CQ35835038-B9429BF5-8950-4019-A461-BCF893CE5A84Q36073764-933E16BE-693E-452F-8325-A4EBEE0E3B49Q36623925-2049A0A6-4A9E-4BE1-B6CA-AB7E2DFBBC32Q36907145-E8BC29FD-5211-431D-B6A2-FAA1A939E3DEQ37321428-176548FD-503A-4214-8AD2-D55BE63212E5Q37507405-0D747B48-02ED-4214-9630-1648F6DED7CDQ37559012-66E821C1-BD41-46DE-8833-0F9688C0F109Q37851076-8CC0EEA9-469B-4BFC-836F-D4DB0AC198C2Q38720370-98D0C68D-AE71-45F1-9908-7E16E1934E55Q39454124-453B1301-4897-46E8-8611-4632CF044EDCQ39547351-739AEE8C-04B7-4D11-8BF2-0BAD4C03C165Q39947245-90C4C947-D5D6-4091-88B8-25AF595DE851Q40360938-1418DC27-A506-43EE-8B97-922F92EA1BBCQ40572969-5F4048F7-A118-4CC5-BA16-1C3C027D0307Q41098347-AE317A73-BC6D-44E4-9C5A-2560511C056FQ41931733-B22AAF6E-31FF-475E-833C-9319399991EAQ42358657-E38CD6ED-B619-486F-9276-52E4F1FC4AA5Q42503209-0E6D370B-0B3B-43C4-B1E5-A6BFB720E9EEQ43600400-7E1DAB6A-9301-4E79-A9C6-E4C263F65F59Q44403194-D87F8730-C219-4DA1-BF2B-F836D9C12B6FQ46696918-31F4C31C-CA08-4DE6-A1A1-C0F12A8F5B44Q47400582-0DF5AC15-107B-48CC-AA6F-205FF5B980F1Q53025316-7C26A8F9-A44B-49DD-8018-71ADB6274CB4Q57738618-230ADAA7-0351-40C8-B13D-725DFBCC126DQ58097975-E645A7B4-ECCA-42B2-9CFB-719EE4B3DC2DQ73427676-01FA9ADD-83E2-4D84-801A-2BD20BA61BF5Q91963226-97FE0E40-667F-4F6F-914D-BF3708CF8AB7
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Egidio Iorio
@ast
Egidio Iorio
@en
Egidio Iorio
@es
Egidio Iorio
@nl
Egidio Iorio
@sl
type
label
Egidio Iorio
@ast
Egidio Iorio
@en
Egidio Iorio
@es
Egidio Iorio
@nl
Egidio Iorio
@sl
prefLabel
Egidio Iorio
@ast
Egidio Iorio
@en
Egidio Iorio
@es
Egidio Iorio
@nl
Egidio Iorio
@sl
P1053
M-7077-2017
P106
P1153
6701890907
P21
P31
P3829
P496
0000-0001-6673-3838